Drug Type Antibody drug conjugate (ADC) |
Synonyms AR 081, AR081 |
Target |
Action inhibitors |
Mechanism DLL3 inhibitors(Delta-like protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Discovery | South Korea | 27 Oct 2023 | |
| Solid tumor | Discovery | South Korea | 27 Oct 2023 |






